Estimation of mutation frequencies in normal mammalian cells and the development of cancer

Seminars in Cancer Biology

Volumn 8, Issue 6, 1998, Pages 407-419

  Turker, Mitchell S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aging; Cancer; Mutant frequencies; Mutator phenotype; Somatic cell mutations

Indexed keywords

AGE; ANIMAL CELL; CANCER CELL; CANCER RESEARCH; CARCINOGENESIS; CELL CYCLE S PHASE; CONTROLLED STUDY; DIPLOIDY; HUMAN; HUMAN CELL; MAMMAL CELL; MITOSIS; MOUSE; MUTATION RATE; NONHUMAN; PHENOTYPE; REVIEW; SOMATIC CELL; STEM CELL;

EID: 0031987280     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0112     Document Type: Article

References (143)

1. 1. Weinberg RA (1995) The molecular basis of oncogenes and tumor suppressor genes. Ann NY Acad Sci 758:331-338
2. 2. Weinberg RA (1996) How cancer arises. Sci Am 275:62-70
3. 3. Huebner K, Ohta M, Lubinski J, Berd D, Maguire HC Jr (1996) Detection of specific genetic alterations in cancer cells. Semin Oncol 23:22-30
4. 4. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colon cancer. Cell 87:159-170
5. 5. Kinzler KW, Vogelstein B (1997) Gatekeepers and caretakers. Nature 386:761-763
6. 6. Pierreti M, Powell DE, Gallion HH, Case EA, Conway PS, Turker MS (1995) Alterations on chromosome 17 distinguish different types of epithelial ovarian tumors. Human Pathol 26:393-397
7. 7. Carothers AM (1997) DNA damage, mutation, and repair. Encycl Cancer 1:484
8. 8. Nicklas RB (1997) How cells get the right chromosomes. Science 275:632-637
9. 9. Orr-Weaver TL, Weinberg RA (1998) A checkpoint on the road to cancer. Nature 392:223-224
10. 10. Loeb LA, Christians FC (1996) Multiple mutations in human cancers. Mutat Res 350:279-286
11. 11. Loeb LA (1998) Foundations in cancer research: cancer cells exhibit a mutator phenotype. Adv Cancer Res 25-56
12. 12. Tomlinson IP, Novelli MR, Bodmer WF (1996) The mutation rate and cancer. Proc Natl Acad Sci USA 93:14800-14803
13. 13. Simpson AJG (1997) The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res 209-240
14. 14. Cooper DN, Krawczak M, Antonarakis SE (1998) The nature of human gene mutation, in The Genetic Basis of Human Cancer (Vogelstein B, Kinzler KW, eds) pp. 65-94. McGraw-Hill Companies, Inc., New York
15. 15. Weber JL, May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388
16. 16. Ramel C (1997) Mini- and microsatellites. Environ Health Perspect 105, supplement 4:781-789
17. 17. Richards RI, Sutherland GR (1997) Dynamic mutation: possible mechanisms and significance in human disease. Trends Biochem Sci 22:432-436
18. 18. Moutou C, Vincent M-C, Biancalana V, Mandel J-L (1997) Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Human Mol Genet 6:971-979
19. 19. Wöhrle D, Schwemmle S, Steinbach P (1996) DNA methylation and triplet repeat stability: New proposals addressing actual questions on the CGG repeat of fragile X syndrome. Am J Med Genet 64:266-267
20. 20. Ito Y, Tanaka F, Yamamoto M, Doyu M, Nagamatsu M, Riku S, Mitsuma T, Sobue G (1998) Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA). Neurochem Res 23:25-32
21. 21. Martorell L, Monckton DG, Gamez J, Johnson KJ, Gich I, de Munain AL, Baiget M (1998) Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Human Mol Genet 7:307-312
22. 22. Eden S, Cedar H (1994) Role of DNA methylation in the regulation of transcription. Curr Opin Genet Dev 4:255-259
23. 23. Heard E, Clerc P, Avner P (1997) X-chromosome inactivation in mammals, in Annual Review of Genetics, Vol. 31 (Campbell A, Anderson W, Jones EW, eds) pp 571-610. Annual Reviews Inc., Palo Alto, CA
24. 24. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa J-P (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 141-196
25. 25. Nelson SL, Jones IM, Fuscoe JC, Burkhart-Schultz K, Grosovsky AJ (1995) Mapping the end points of large deletions affecting the hprt locus in human peripheral blood cells and cell lines. Radiat Res 141:2-10
26. 26. Turker MS, Pieretti M, Kumar S (1997) Molecular evidence for the induction of large interstitial deletions on mouse chromosome 8 by ionizing radiation. Mutat Res 374:201-208
27. 27. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948
28. 28. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935
29. 29. Tischfield JA (1997) Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination. Am J Human Genet 61:995-999
30. 30. Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386:623-627
31. 31. Robertson KD, Jones PA (1997) Chromatin dynamics' 97: dynamic interrelationships between DNA replication, methylation, and repair. Am J Hum Genet 61:1220-1224
32. 32. Khattar NH, Turker MS (1997) A role for certain mouse Aprt sequences in resistance to toxic adenine analogs. Somat Cell Mol Genet 23:51-61
33. 33. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484
34. 34. Albertini RJ, Hayes RB (1997) Somatic cell mutations in cancer epidemiology. IARC Sci Publ 142:159-184
35. 35. Albertini RJ, Nicklas JA, O'Neill JP, Robison SH (1990) In vivo somatic mutations in humans: measurement and analysis. Annu Rev Genet 24:305-326
36. 36. Albertini RJ (1985) Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutat Res 150:411-422
37. 37. Morley AA, Trainor KJ, Dempsey JL, Seshardi RS (1985) Methods for study of mutations and mutagenesis in human lymphocytes. Mutat Res 147:363-367
38. 38. Jones IM, Thomas CB, Tucker B, Thompson CL, Pleshanov P, Vorobtsova I, Moore DH II (1995) Impact of age and environment on somatic mutation at the hprt gene of T lymphocytes in humans. Mutat Res 338:129-139
39. 39. Morley AA, Cox S, Holliday R (1982) Human lymphocytes resistant to 6-thioguanine increase with age. Mech Age Dev 19:21-26
40. 40. Akiyama M, Kyoizumi S, Hirai Y, Kusunoki Y, Iwamoto KS, Nakamura N (1995) Mutation frequency in human blood cells increases with age. Mutat Res 338:141-149
41. 41. Albertini RJ, Nicklas JA, O'Neill JP (1993) Somatic cell gene mutations in humans: biomarkers for genotoxicity. Environ Health Perspect 101:193-201
42. 42. Messing K, Ferraris J, Bradley WEC, Swartz J, Seifert AM (1989) Mutant frequency of radiotherapy technicians appears to be associated with recent dose of ionizing radiation. Health Phys 57:537-544
43. 43. Cole J, Skopek TR (1994) International Commission for Protection against Environmental Mutagens and Carcinogens, Working paper 3, Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res 304:33-106
44. 44. Tates AD, van Dam FJ, Natarajan AT, Zwinderman AH, Osanto S (1994) Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study. Mutat Res 307:293-306
45. 45. Tates AD, Grummit T, van Dam FJ, de Zwart F, Kasper FJ, Rothe R, Stirn H, Zwinderman AH, Natarajan AT (1994) Measurement of frequencies of HPRT mutants, chromosomal aberrations, micronuclei, sister-chromatid exchanges and cells with high frequencies of SCEs in styrene/dichloromethane-exposed workers. Mutat Res 313:249-262
46. 46. Nicklas JA, Hunter TC, O'Neill JP, Albertini RJ (1989) Molecular analyses of in vivo HPRT mutations in human T-lymphocytes: III. Longitudinal study of HPRT gene structural alterations and T-cell clonal origins. Mutat Res 215:147-160
47. 47. Morley AA, Grist SA, Turner DR, Kutlaca A, Bennett G (1990) Molecular nature of in vivo mutations in human cells at the autosomal HLA-A locus. Cancer Res 50:4584-4587
48. 48. Grist SA, McCarron M, Kutlaca A, Turner DR, Morley AA (1992) In vivo human somatic mutation: Frequency and spectrum with age. Mutat Res 266:189-196
49. 49. Langlois RG, Bigbee WL, Jensen RH (1990) The glycophorin A assay for somatic cell mutations in humans. Prog Clin Biol Res 340C:47-56
50. 50. Jensen RH, Langlois RG, Bigbee WL, Grant SG, Moore D II, Pilinskaya M, Vorobtsova I, Pleshanov P (1995) Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat Res 141:129-135
51. 51. Jensen RH, Grant SG, Langlois RG, Bigbee WL (1991) Somatic cell genotoxicity at the glycophorin A locus in humans. Prog Clin Biol Res 372:329-339
52. 52. Jensen RH, Langlois RG, Bigbee WL, Grant SG, Moore D III, Pilinskaya M, Vorobtsova I, Pleshanov P (1995) Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat Res 141:129-135
53. 53. Jensen RH, Reynolds JC, Robbins J, Bigbee WL, Grant SG, Langlois RG, Pineda JD, Lee T, Barker WC (1997) Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131. Radiat Res 147:747-752
54. 54. Bigbee WL, Fuscoe JC, Grant SG, Jones IM, Gorvad AE, Harrington-Brock K, Strout CL, Thomas CB, Moore MM (1998) Human in vivo somatic mutation measure at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies. Mutat Res 397:119-136
55. 55. Martin GM, Ogburn CE, Colgin LM, Gown AM, Edland SD, Monnat RJ Jr (1996) Somatic mutations are frequent and increase with age in human kidney epithelial cells. Human Mol Genet 5:215-221
56. 56. Turker MS, Monnat Jr. R, Fukuchi K, Johnston PA, Ogburn CE, Weller RE, Park JE, Martin GM (1988) A novel unstable class of 6-thioguanine resistance cells from dog and human kidneys. Cell Biol Toxicol 4:211-223
57. 57. Albertini RJ, Clark LS, Nicklas JA, O'Neill JP, Hui TE, Jostes R (1997) Radiation quality affects the efficiency of induction and the molecular spectrum of HPRT mutations in human T cells. Radiat Res 148:S76-S86
58. 58. McGregor WG, Maher VM, McCormick JJ (1994) Kinds and locations of mutations induced in the hypoxanthineguanine phosphoribosyltransferase gene of human T-lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase. Cancer Res 54:4207-4213
59. 59. Huebner K, Ohta M, Lubinski J, Berd D, Maguire HC Jr (1996) Molecular analysis and comparison of radiation-induced large deletions of the HPRT locus in primary human skin fibroblasts. Radiat Res 145:481-490
60. - mutants. Mutat Res 349:33-41
61. 61. Hakoda M, Hirai Y, Akiyama M, Yamanaka H, Terai C, Kamatani N, Kashiwazaki S (1995) Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs the level of multipotent stem cells. Hum Genet 96:674-680
62. 62. Imai Y, Tsurutani N, Oda H, Inoue T, Ishikawa T (1998) Genetic instability and mutation of the TGF-β-receptor-II gene in ampullary carcinomas. Int J Cancer 76:407-411
63. 63. Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Tomita N, Ohue M, Hayakawa T (1997) Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas. Cancer Lett 112:251-256
64. 64. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1276-1277
65. 65. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B (1997) Familial colorectal cancer in Ashkenzim due to a hypermutable tract in APC. Nature Genet 17:79-83
66. 66. Dutkowski RT, Lesh R, Staiano-Coico L, Thaler H, Darlington GJ, Weksler ME (1985) Increased chromosomal instability in lymphocytes from elderly humans. Mutat Res 149:505-512
67. 67. Ganguly BB (1993) Cell division, chromosomal damage and micronucleus formation in peripheral lymphocytes of healthy donors: related to donor's age. Mutat Res 295:135-148
68. 2 repair and aging: influence of donor age on chromosomal aberrations in human lymphocytes. Mutat Res 295:55-62
69. 69. Ramsey MJ, Moore DH II, Briner JF, Lee DA, Olsen LA, Senft JR, Tucker JD (1995) The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res 338:95-106
70. 70. Dass SB, Heflich RH, Casciano DA (1998) Mutational response at the splenic T-lymphocyte hprt locus in mice treated as neonates: contrasting effects of the carcinogens N-ethyl-N-nitrosourea, dimethylnitrosamine, and 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Environ Mol Mutagen 31:243-247
71. 71. Dass SB, Heflich RH, Casciano DA (1997) The mutagenic response at the ouabain resistance locus in T cells of mice exposed to N-ethyl-N-nitrosourea parallels the response at the Hprt locus and correlated with mutation target size. Carcinogenesis 18:2233-2237
72. 72. Jones IM, Burkhart-Schultz K, Carrano AV (1985) A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat Res 147:97-105
73. 73. Grdina DJ, Kataoka Y, Basic I, Perrin J (1992) The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyltransferase locus in mouse splenocytes when administered prior to or following irradiation. Carcinogenesis 13:811-814
74. 74. Lorenz R, Gollner T, Hempel K (1990) Quantification of thioguanine-resistant lymphocytes from mice irradiated in vivo. Environ Health Perspect 88:129-132
75. 75. Ward Jr JB, Ammenheuser MM, Ramanujam VM, Morris DL, Whorton Jr EB, Legator MS (1992) The mutagenic effects of low level sub-acute inhalation exposure to benzene in CD-1 mice. Mutat Res 268:49-57
76. 76. Martus HJ, Dollé MET, Gossen JA, Boerrigter METI, Vijg J (1995) Use of transgenic mouse models for studying somatic mutations in aging. Mutat Res 338:203-213
77. 77. Dempsey JL, Pfeiffer M, Morley AA (1993) Effect of dietary restriction on in vivo somatic mutation in mice. Mutat Res 291:141-145
78. 78. Zhang XB, Urlando C, Tao KS, Heddle JA (1995) Factors affecting somatic mutation frequencies in vivo. Mutat Res 338:189-201
79. +ATPase alpha subunit identifies known and previously unidentified amino acid residues that alter ouabain sensitivity - implications for ouabain binding. Eur J Biochem 248:488-495
80. 80. Horn PL, Turker MS, Ogburn CE, Disteche CM, Martin GM (1984) A cloning assay for 6-thioguanine resistance provides evidence against certain somatic mutational theories of aging. J Cell Physiol 121:309-315
81. +/- heterozygous mouse. Mutat Res 351:67-77
82. 82. Martin GM, Smith AC, Ketterer DJ, Ogburn CE, Disteche CM (1985) Increased chromosomal aberrations in first metaphases of cells isolated from the kidneys of aged mice. Isr J Med Sci 21:296-301
83. 83. de Boer JG, Provost S, Gorelick N, Tindall K, Glickman BW (1998) Spontaneous mutation in lacI transgenic mice: a comparison of tissues. Mutagenesis 13:109-114
84. 84. Gossen JA, de Leeuw WJ, Vijg J (1994) LacZ transgenic mouse models: their application in genetic toxicology. Mutat Res 307:451-459
85. 85. Leach EG, Narayanan L, Havre PA, Gunther EJ, Yeasky TM, Glazer PM (1996) Tissue specificity of spontaneous point mutations in lambda supF transgenic mice. Environ Mol Mutagen 28:459-464
86. 86. Dollé MET, Giese H, Hopkins CL, Martus HJ, Hausdorff Jm, Vijg J (1997) Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nature Genet 17:368-370
87. 87. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL, Short JM (1991) Spectra of spontaneous and mutagen-induced mutations in the lacl gene in transgenic mice. Proc Natl Acad Sci USA 88:7958-7962
88. 88. Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM (1997) Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci USA 94:3122-3127
89. 89. Walker VE, Gorelick NJ, Andres JL, Craft TR, de Boer JG, Glickman BW, Skopek TR (1996) Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res 56:4654-4661
90. 90. de Boer JG, Erfle H, Walsh D, Holcroft J, Provost JS, Rogers B, Tindall KR, Glickman BW (1997) Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice. Environ Mol Mutagen 30:273-286
91. 91. Tinwell H, Liegibel U, Krebs O, Schmezer P, Favor J, Ashby J (1995) Comparison of lacI and lacZ transgenic mousemutation assays: an EU-sponsored interlaboratory study. Mutat Res 335:185-190
92. 92. Tao KS, Urlando C, Heddle JA (1993) Comparison of somatic mutation in a transgenic versus host locus. Proc Natl Acad Sci USA 90:10681-10685
93. 93. Dollě ME, Martus HJ, Gossen JA, Boerrigter ME, Vijg J (1996) Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations. Mutagenesis 11:111-118
94. 94. Ono T, Miyamura Y, Ikehata H, Yamanaka H, Kurishita A, Yamamoto K, Suzuki T, Nohmi T, Hayashi M, Sofuni T (1995) Spontaneous mutant frequency of lacZ gene in spleen of transgenic mouse increases with age. Mutat Res 338:183-188
95. 95. Lee AT, DeSimone C, Cerami A, Bucala R (1994) Comparative analysis of DNA mutations in lacI transgenic mice with age. FASEB J 8:545-550
96. 96. Dempsey JL, Odagiri Y, Morley AA (1993) In vivo mutations at the H-2 locus in mouse lymphocytes. Mutat Res 285:45-51
97. 97. Stambrook PJ, Shao C, Stockelman M, Boivin G, Engle SJ, Tischfield JA (1996) APRT: A versatile in vivo resident reporter of local mutation and loss of heterozygosity. Environ Mol Mutagen 28:471-482
98. 98. Prolla TA, Baker SM, Harris AC, Tsao J-L, Yao X, Bronner CE, Zheng B, Gordon M, Reneker J, Arnheim N, Shibata D, Bradley A, Liskay RM (1998) Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nature Genet 18:276-279
99. 99. Miller RA (1995) Gerontology: the study of aging as the study of cancer, in Molecular Aspects of Aging (Esser K, Martin GM, eds) pp 265-278. John Wiley and Sons Ltd., New York
100. 100. Meuth M (1996) Patterns of mutation in cancer cells. Cancer Surv 28:33-46
101. 101. Bhattacharyya NP, Ganesh A, Phear G, Richards B, Skandalis A, Meuth M (1995) Molecular analysis of mutations in mutator colorectal carcinoma cell lines. Human Mol Genet 4:2057-2064
102. 102. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M (1994) Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 91:6319-6323
103. 103. Gualberto A, Aldape K, Kozakiewicz K, Tlsty TD (1998) An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc Natl Acad Sci USA 95:5166-5171
104. 104. Smith L, Liu SJ, Goodrich L, Jacobson D, Degnin C, Bentley N, Carr A, Flaggs G, Keegan K, Hoekstra M, Thayer MJ (1998) Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest. Nature Genet 19:39-46
105. 105. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392:223-224
106. 106. Baross-Francis A, Andrew SE, Penney JE, Jirik FR (1998) Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc Natl Acad Sci USA 95:8739-8743
107. 106a. Lengauer C, Kinzler KW, Vogelstein B (1997) DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci (USA) 94:2103-2105
108. 107. Jahner D, Jaenisch R (1985) Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity. Nature 315:594-597
109. 108. Toyota M, Ho C, Ahuja N, Jair K-W, Ohe-Toyota M, Herman JG, Baylin SB, Issa J-PJ (1998) Epigenetic instability in colorectal cancer. Mutat Res Submitted
110. 109. Veigl ML, Kastrui L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li G-M, Drummond J, Modrich PL, Sedwick WD, Markowitz SD (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 95:8698-8702
111. 110. Chen RZ, Petterson U, Beard C, Jackson-Grusby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395:89-93
112. 111. Laird PW, Jaenisch R (1996) The role of DNA methylation in cancer genetics and epigenetics. Annu Rev Genet 30:441-464
113. 112. Chang WP, Little JB (1992) Persistently elevated frequency of spontaneous mutations in progeny of CHO clones surviving X-irradiation: Association with delayed reproductive death phenotype. Mutat Res 270:191-199
114. 113. Holmberg K, Falt S, Johansson A, Lambert B (1993) Clonal chromosome aberrations and genomic instability in X-irradiated human T-lymphocyte cultures. Mutat Res 286:321-330
115. 114. Kadhim MA, MacDonald DA, Goodhead DT, Lorimore SA, Marsden SJ, Wright EG (1992) Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 355:738-740
116. 115. Kadhim MA, Lorimore SA, Townsend KMS, Goodhead DT, Buckle VJ, Wright EG (1995) Radiation-induced genomic instability: delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells. Int J Radiat Biol 67:287-293
117. 116. Marder BA, Morgan WF (1993) Delayed chromosomal instability induced by DNA damage. Mol Cell Biol 13:6667-6677
118. 117. Grosovsky AJ, Parks KK, Giver CR, Nelson SL (1996) Clonal analysis of delayed karotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol Cell Biol 16:6252-6262
119. 118. Harper K, Lorimore SA, Wright EG (1997) Delayed appearance of radiation-induced mutations at the Hprt locus in muring hemopoietic cells. Exp Hematol 25:263-269
120. 119. Grosovsky AJ, de Boer JG, de Jong EA, Drobetsky EA, Glickman BW (1988) Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced mutations in mammalian cells. Proc Natl Acad Sci USA 85:185-188
121. 120. Benjamin MB, Little JB (1992) X rays induce interallelic homologous recombination at the human thymidine kinase gene. Mol Cell Biol 12:2730-2738
122. 121. Aghamohammadi SZ, Morris T, Stevens DL, Thacker J (1992) Rapid screening for deletion mutations in the hprt gene using the polymerase chain reaction: X-ray and α-particle mutant spectra. Mutat Res 269:1-7
123. 122. Zhu LX, Waldren CA, Vannais D, Hei TK (1996) Cellular and molecular analysis of mutagenesis induced by charged particles of defined linear energy transfer. Radiat Res 145:251-259
124. 123. McGuinness SM, Shibuya ML, Ueno AM, Vannais DB, Waldren CA (1995) Mutant quantity and quality in mammalian cells (AL) exposed to cesium-137 gamma radiation: effect of caffeine. Radiat Res 142:247-255
125. 124. Loft S, Poulsen HE (1996) Cancer risk and oxidative DNA damage in man. J Mol Med 74:297-312
126. 125. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547-581
127. 126. Moriya M (1993) Single-stranded shuttle phagemid for mutagenesis studies in mammalian cells: 8-oxoguanine in DNA induces targeted G.C → T.A transversions in simian kidney cells. Proc Natl Acad Sci USA 90:1122-1126
128. 127. Hei TK, Liu SX, Waldren C (1998) Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA 95:8103-8107
129. 128. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggit RC, Boland CR (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56:1237-1240
130. 129. Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kowdley KV, Hecker LM, Byrd DR (1995) Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264-4267
131. 129a. Jackson AL, Chen R, Loeb LA (1998) Induction of microsatellite instability by oxidative damage. Proc Natl Acad Sci (USA) 95:12468-12473
132. 130. Nusbaum NJ (1998) The aging/cancer connection. Am J Med Sci 315:40-49
133. 131. Cohen HJ (1994) Biology of aging as related to cancer. Cancer 74:2092-2100
134. 132. Freedman ML (1996) Cancer and the elderly, in Encyclopedia of Gerontology, Vol. 2 (Birren JE, ed.) pp 223-243. Academic Press, Inc, San Diego
135. 133. Martin GM, Austad SN, Johnson TE (1996) Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nature Genet 13:25-34
136. 134. Meltzer PS, Trent JM (1998) Chromosome rearrangements in human solid tumors, in The Genetic Basis of Human Cancer (Volgelstein B, Kinzler KW, eds) pp. 143-160. McGraw-Hill Companies, Inc., New York
137. 135. Losi L, Fante R, Di Gregorio C, Aisoni ML, Lanza G, Maestri I, Roncucci L, Pedroni M, Ponz de Leon M (1995) Biologic characterization of hereditary non-polyposis colorectal cancer. Am J Clin Pathol 103:265-270
138. 136. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ (1998) Nucleotide excision repair syndromes: xeroderma pigmentosa, cockayne syndrome, and trichothiodystrophy, in The Genetic Basis of Human Cancer (Volgelstein B, Kinzler KW, eds) pp. 245-274. McGraw-Hill Companies, Inc., New York
139. 137. Gatti RA (1998) Ataxia-telangiectasia, in The Genetic Basis of Human Cancer (Vogelstein B, Kinzler KW, eds) pp. 275-300. McGraw-Hill Companies, Inc., New York
140. 138. Malkin D (1998) Li-Fraumeni syndrome, in The Genetic Basis of Human Cancer (Vogelstein B, Kinzler KW, eds) pp. 393-408. McGraw-Hill Companies, Inc., New York
141. 139. Rudin CM, Thompson CB (1998) Apoptosis and cancer, in The Genetic Basis of Human Cancer (Vogelstein B, Kinzler KW, eds) pp. 193-204. McGraw-Hill Companies, Inc., New York
142. 140. Pieretti M, Cavalieri C, Conway PS, Gallion HH, Powell DE, Turker MS (1995) Genetic alterations distinguish different types of ovarian cancer. Int J Cancer 64:434-440
143. 141. Pieretti M, Turker MS (1997) Mutation, aging, and ovarian cancer. Lancet 349:700-701